Financials
- Market Capitalization 946.15 M
- Employee 161
- Founded 2002
- CEO N/A
- Website www.dbv-technologies.com
- Headquarter France
- FIGI BBG0076D3T39
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-23.21
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2498 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.17 USD | -2.25% | -6.47% | +11.28% | +82.35% | 963.91 M USD | ||
| 2506 | SLDB Solid Biosciences Inc. - Common Stock | 9.72 USD | -6.72% | -12.20% | +33.70% | +70.53% | 956.93 M USD | ||
| 2524 | LBRX LB Pharmaceuticals Inc - Common Stock | 32.25 USD | -2.12% | -6.03% | +12.96% | +69.74% | 924.82 M USD | ||
| 2525 | ABUS Arbutus Biopharma Corporation - Common Stock | 4.67 USD | -2.71% | -6.22% | +8.60% | +44.58% | 922.50 M USD |